Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank A Post

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2011
Contribution of vitamin D(2) to total vitamin D in HIV-positive patientsRosemary E J Clarke, Lucy J Campbell, Lewis Couchman, et al.
AIDS (London, England)|June 27, 2024
Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxilLucy Campbell, Birgit Barbini, Ben Cromarty, et al.
AIDS (London, England)|July 2, 2014
Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicityJean C Yombi, Anton Pozniak, Marta Boffito, et al.
BMC Infectious Diseases|January 22, 2013
Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort studyJulia Shrosbree, Lucy J Campbell, Fowzia Ibrahim, et al.
AIDS (London, England)|July 1, 2010
Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphataseTanya Welz, Kate Childs, Fowzia Ibrahim, et al.
Transplantation|September 29, 2015
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant RecipientsEsther Gathogo, Mark Harber, Sanjay Bhagani, et al.
Transplantation|December 3, 2025
The Impact of Recipient HIV Status on Kidney Transplant Outcomes in the United Kingdom: Have Previous Studies Overestimated Risk?Marena L Gray, Samuel J Tingle, Mohamed Elzawahry, et al.
HIV Medicine|February 1, 2026
Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapyRhianna Sheridan, Yasmin Osei-Kuffour Ekert, Lucy Campbell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2020
Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case SeriesKate Childs, Frank A Post, Claire Norcross, et al.
AIDS (London, England)|February 18, 2015
Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavirLisa Hamzah, Lucy Campbell, Emily Wandolo, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2011
Contribution of vitamin D(2) to total vitamin D in HIV-positive patientsRosemary E J Clarke, Lucy J Campbell, Lewis Couchman, et al.
AIDS (London, England)|June 27, 2024
Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxilLucy Campbell, Birgit Barbini, Ben Cromarty, et al.
AIDS (London, England)|July 2, 2014
Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicityJean C Yombi, Anton Pozniak, Marta Boffito, et al.
BMC Infectious Diseases|January 22, 2013
Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort studyJulia Shrosbree, Lucy J Campbell, Fowzia Ibrahim, et al.
AIDS (London, England)|July 1, 2010
Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphataseTanya Welz, Kate Childs, Fowzia Ibrahim, et al.
Transplantation|September 29, 2015
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant RecipientsEsther Gathogo, Mark Harber, Sanjay Bhagani, et al.
Transplantation|December 3, 2025
The Impact of Recipient HIV Status on Kidney Transplant Outcomes in the United Kingdom: Have Previous Studies Overestimated Risk?Marena L Gray, Samuel J Tingle, Mohamed Elzawahry, et al.
HIV Medicine|February 1, 2026
Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapyRhianna Sheridan, Yasmin Osei-Kuffour Ekert, Lucy Campbell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2020
Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case SeriesKate Childs, Frank A Post, Claire Norcross, et al.
AIDS (London, England)|February 18, 2015
Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavirLisa Hamzah, Lucy Campbell, Emily Wandolo, et al.
Pageof 18